This case was about “Gladskin” products used for skin conditions such as eczema, acne, rosacea and other skin irritations such as itching and redness involving the Staphylococcus auresu bacteria. The District Court of The Hague ruled that no marketing authorization had been granted for them as referred to in the Medicines Act. The Hague Court of Appeal agreed with the District Court. In designing the table item, the legislator had stayed within the boundaries of EU law regulations in the field of VAT.
Source: futd.nl
